Melanoma-intrinsic NR2F6 activity regulates anti-tumor immunity
H. Kim, Y. Feng, R. Murad, V. Klepsch, G. Baier, Z. A. Ronai
This study identifies NR2F6 as a melanoma-intrinsic regulator of anti-tumor immunity, showing that its inhibition enhances immunotherapy response and tumor suppression.
bioRxiv · Sep 14, 2022 · PreprintCancer Biology